Prevention of macular oedema after cataract surgery in patients with diabetes mellitus
Nowadays, diabetes mellitus is an important public health problem. Together, population growth, prevalence of obesity, and a sedentary lifestyle has led to an increased number of individuals with diabetes mellitus. Globally, cataracts remain the leading cause of blindness and the second cause of vis...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN RU |
| Publicado: |
Endocrinology Research Centre
2017
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/ef2bd5240d884811a028be47cca28b23 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:ef2bd5240d884811a028be47cca28b23 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:ef2bd5240d884811a028be47cca28b232021-11-14T09:00:21ZPrevention of macular oedema after cataract surgery in patients with diabetes mellitus2072-03512072-037810.14341/DM8729https://doaj.org/article/ef2bd5240d884811a028be47cca28b232017-12-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/8729https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Nowadays, diabetes mellitus is an important public health problem. Together, population growth, prevalence of obesity, and a sedentary lifestyle has led to an increased number of individuals with diabetes mellitus. Globally, cataracts remain the leading cause of blindness and the second cause of visual impairment among patients with diabetes mellitus. Phacoemulsification with intraocular lens implantation is the standardised surgical technique to treat cataracts. Advances in cataract surgical techniques have significantly decreased the incidence of complications. However, surgery may not be safe, as the risk of complications increases in patients with diabetes mellitus with pre-existing blood–ocular barrier pathology. Cystoid macular oedema is one of the most severe postoperative complications after cataract surgery. It is considered the most important cause of suboptimal visual acuity and strongly affects early recovery. The optimal pharmacological therapy for prevention of CME following cataract surgery in patients with diabetes mellitus continues to be debated and needs further investigation.Irina A. BashinaMichael A. FrolovDmitriy V. LipatovEndocrinology Research Centrearticlediabetes mellituscataractcystoid macular edemadiabetic macular edemaNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 20, Iss 5, Pp 350-355 (2017) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN RU |
| topic |
diabetes mellitus cataract cystoid macular edema diabetic macular edema Nutritional diseases. Deficiency diseases RC620-627 |
| spellingShingle |
diabetes mellitus cataract cystoid macular edema diabetic macular edema Nutritional diseases. Deficiency diseases RC620-627 Irina A. Bashina Michael A. Frolov Dmitriy V. Lipatov Prevention of macular oedema after cataract surgery in patients with diabetes mellitus |
| description |
Nowadays, diabetes mellitus is an important public health problem. Together, population growth, prevalence of obesity, and a sedentary lifestyle has led to an increased number of individuals with diabetes mellitus. Globally, cataracts remain the leading cause of blindness and the second cause of visual impairment among patients with diabetes mellitus.
Phacoemulsification with intraocular lens implantation is the standardised surgical technique to treat cataracts. Advances in cataract surgical techniques have significantly decreased the incidence of complications. However, surgery may not be safe, as the risk of complications increases in patients with diabetes mellitus with pre-existing blood–ocular barrier pathology. Cystoid macular oedema is one of the most severe postoperative complications after cataract surgery. It is considered the most important cause of suboptimal visual acuity and strongly affects early recovery.
The optimal pharmacological therapy for prevention of CME following cataract surgery in patients with diabetes mellitus continues to be debated and needs further investigation. |
| format |
article |
| author |
Irina A. Bashina Michael A. Frolov Dmitriy V. Lipatov |
| author_facet |
Irina A. Bashina Michael A. Frolov Dmitriy V. Lipatov |
| author_sort |
Irina A. Bashina |
| title |
Prevention of macular oedema after cataract surgery in patients with diabetes mellitus |
| title_short |
Prevention of macular oedema after cataract surgery in patients with diabetes mellitus |
| title_full |
Prevention of macular oedema after cataract surgery in patients with diabetes mellitus |
| title_fullStr |
Prevention of macular oedema after cataract surgery in patients with diabetes mellitus |
| title_full_unstemmed |
Prevention of macular oedema after cataract surgery in patients with diabetes mellitus |
| title_sort |
prevention of macular oedema after cataract surgery in patients with diabetes mellitus |
| publisher |
Endocrinology Research Centre |
| publishDate |
2017 |
| url |
https://doaj.org/article/ef2bd5240d884811a028be47cca28b23 |
| work_keys_str_mv |
AT irinaabashina preventionofmacularoedemaaftercataractsurgeryinpatientswithdiabetesmellitus AT michaelafrolov preventionofmacularoedemaaftercataractsurgeryinpatientswithdiabetesmellitus AT dmitriyvlipatov preventionofmacularoedemaaftercataractsurgeryinpatientswithdiabetesmellitus |
| _version_ |
1718429563527102464 |